IRIS - Res&Arch Institutional Research Information System - Research & Archive

FALZETTI, Franca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.527
EU - Europa 2.757
AS - Asia 2.442
SA - Sud America 410
AF - Africa 67
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 9.209
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.450
SG - Singapore 1.092
IT - Italia 596
IE - Irlanda 444
CN - Cina 401
BR - Brasile 322
RU - Federazione Russa 301
HK - Hong Kong 287
DE - Germania 258
VN - Vietnam 253
UA - Ucraina 245
SE - Svezia 229
FI - Finlandia 196
FR - Francia 159
GB - Regno Unito 110
KR - Corea 93
IN - India 65
BD - Bangladesh 46
TR - Turchia 44
RO - Romania 43
MX - Messico 36
AR - Argentina 32
BE - Belgio 30
CA - Canada 26
CZ - Repubblica Ceca 25
AT - Austria 23
PL - Polonia 23
IQ - Iraq 22
NL - Olanda 20
UZ - Uzbekistan 19
JP - Giappone 17
ZA - Sudafrica 16
ES - Italia 15
PK - Pakistan 15
SA - Arabia Saudita 13
EC - Ecuador 12
ET - Etiopia 12
CO - Colombia 11
MA - Marocco 11
CH - Svizzera 10
LT - Lituania 10
PH - Filippine 10
CL - Cile 8
EG - Egitto 8
ID - Indonesia 7
MY - Malesia 7
PY - Paraguay 7
AZ - Azerbaigian 6
JO - Giordania 6
LB - Libano 6
VE - Venezuela 6
GR - Grecia 5
KE - Kenya 5
OM - Oman 5
BO - Bolivia 4
NP - Nepal 4
QA - Qatar 4
TN - Tunisia 4
AE - Emirati Arabi Uniti 3
AU - Australia 3
DO - Repubblica Dominicana 3
GE - Georgia 3
IL - Israele 3
JM - Giamaica 3
KZ - Kazakistan 3
PE - Perù 3
UY - Uruguay 3
AL - Albania 2
BG - Bulgaria 2
DK - Danimarca 2
EU - Europa 2
GT - Guatemala 2
PT - Portogallo 2
TT - Trinidad e Tobago 2
AM - Armenia 1
AO - Angola 1
BZ - Belize 1
CI - Costa d'Avorio 1
CM - Camerun 1
CR - Costa Rica 1
CY - Cipro 1
DJ - Gibuti 1
DM - Dominica 1
DZ - Algeria 1
EE - Estonia 1
GF - Guiana Francese 1
GH - Ghana 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
IM - Isola di Man 1
KG - Kirghizistan 1
KW - Kuwait 1
LV - Lettonia 1
LY - Libia 1
ME - Montenegro 1
ML - Mali 1
MM - Myanmar 1
MN - Mongolia 1
NI - Nicaragua 1
Totale 9.201
Salva come PNG Salva come JPEG
Città #
Singapore 791
Chandler 499
Dublin 444
San Jose 299
San Mateo 299
Hong Kong 287
Perugia 271
Ashburn 234
Boardman 157
Jacksonville 138
Santa Clara 116
Ann Arbor 111
Beijing 103
Munich 101
Moscow 100
Seoul 93
Dong Ket 86
Medford 85
Princeton 83
Lauterbourg 79
Altamura 78
Andover 69
Los Angeles 67
Helsinki 63
New York 63
Turku 62
Lawrence 58
Wilmington 56
Ho Chi Minh City 55
Bucharest 40
Hanoi 33
Houston 32
Brussels 30
Piscataway 29
São Paulo 28
The Dalles 28
Foligno 27
Dallas 26
Saint Petersburg 24
Izmir 23
Council Bluffs 22
Dearborn 22
Des Moines 22
Frankfurt am Main 21
Redwood City 21
Norwalk 20
Brooklyn 19
London 17
Shanghai 17
Tokyo 17
Brno 16
Mexico City 16
Warsaw 15
Bologna 14
Denver 14
Orem 14
Atlanta 13
Rio de Janeiro 13
San Francisco 13
San Paolo di Civitate 13
Chennai 11
Stockholm 11
Vienna 11
Addis Ababa 10
Assisi 10
Falkenstein 10
Falls Church 10
Nuremberg 10
Redmond 10
West Jordan 10
Woodbridge 10
Da Nang 9
Johannesburg 9
Tashkent 9
Auburn Hills 8
Baghdad 8
Barnet 8
Boston 8
Groningen 8
Milan 8
Rome 8
Amsterdam 7
Belo Horizonte 7
Chicago 7
Curitiba 7
Florence 7
Guangzhou 7
Hefei 7
Hải Dương 7
Lahore 7
New Delhi 7
Olomouc 7
Poplar 7
Riyadh 7
Ankara 6
Madrid 6
Montreal 6
Ottawa 6
Padova 6
Phoenix 6
Totale 5.929
Salva come PNG Salva come JPEG
Nome #
Advances in full-haplotype mismatched transplants in acute leukemia 182
Bepridil exhibits anti-leukemic activity associated with NOTCH1 pathway inhibition in chronic lymphocytic leukemia 179
Constitutive phosphorylation of the active Notch1 intracellular domain in chronic lymphocytic leukemia cells with NOTCH1 mutation. 176
Engineering donor mesenchymal cells with IL-7 hastens naive T cell recruitment. 169
Notch1 modulates mesenchymal stem cells mediated regulatory T-cell induction 154
Activated autologous T cells exert an anti-B-cell chronic lymphatic leukemia effect in vitro and in vivo. 150
Engineering donor mesenchymal cells with IL-7 hastens naive T cell recruitment in vitro and supports immunologic reconstitution after HSCT in NOD/SCID mice 143
Graft engineering for allogeneic haploidentical stem cell transplantation 134
Notch signaling sustains the expression of Mcl-1 and the activity of eIF4E to promote cell survival in CLL 134
Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia 130
Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia 129
NOTCH1 Aberrations in Chronic Lymphocytic Leukemia. 129
GATA1 epigenetic deregulation contributes to the development of AML with NPM1 and FLT3-ITD cooperating mutations 129
NPM1 AND FLT3-ITD MUTATIONS SINERGISTICALLY INDUCE GATA1 EPIGENETIC SILENCING IN A AML MOUSE MODEL 126
Mesenchymal cells: a vehicle for gene therapy 123
"Designed" grafts for HLA-haploidentical stem cell transplantation. 123
In Vivo Real Time Monitoring of Stem Cells Homing in Postischemic Tissues 122
γ-Secretase inhibitor I induces apoptosis in chronic lymphocytic leukemia cells by proteasome inhibition, endoplasmic reticulum stress increase and Notch down-regulation. 119
Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces nonrelapse mortality 119
The NOTCH1/CD39 axis: A Treg trip-switch for GvHD 119
Clinical-Grade Expanded Regulatory T Cells Prevent Graft-versus-Host Disease While Allowing a Powerful T Cell Dependent Graft-versus-Leukemia Effect in Murine Models 119
Chronic myeloproliferative disorders: the bone marrow stromal component is not involved in the malignant clone.Di Ianni M, Moretti L, Del Papa B, De Ioanni M, Bonifacio E, Falzetti F, Tabilio A. 118
A new genetic lesion in B-CLL: a NOTCH1 PEST domain mutation. 117
Full haplotype-mismatched hematopoietic stem-cell transplantation: A phase II study in patients with acute leukemia at high risk of relapse 117
Addition of PBPCs to the marrow inoculum allows engraftment of mismatched T cell-depleted transplants for acute leukemia 116
NOTCH1 Is Aberrantly Activated in Chronic Lymphocytic Leukemia Hematopoietic Stem Cells. 116
Engineering mesenchymal cells with interleukin 7 gene: effects on T cell. 18-23. 115
Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia 115
Enhancing Regulatory T Cell Function and Homing to the Gut to Improve graft-versus-host Disease Prevention after Adoptive Transfer in Allogeneic Hematopoietic Transplantation 114
IL-4-dependent Jagged1 expression/processing is associated with survival of chronic lymphocytic leukemia cells but not with Notch activation. 114
Activation of Regulatory T Cells with IL-2 and TNF-alpha to Promote Homing to the Gut and to Improve Acute GvHD Prevention 111
IN VIVO DIRECT MONITORING OF STEM CELLS HOMING IN POSTISCHEMIC TISSUES 111
NPM1 AND FLT3-ITD MUTATIONS COOPERATE TO IMPAIR HEMATOPOIETIC STEM/PROGENITOR CELLS DIFFERENTIATION AND DEREGULATE GATA1 IN A MOUSE MODEL OF AML 109
T regulatory cell separation for clinical application. 109
Cytogenetic/mutation profile of chronic lymphocytic leukemia/malignant melanoma collision tumors of the skin 109
A revised NOTCH1 mutation frequency still impacts survival while the allele burden predicts early progression in chronic lymphocytic leukemia 108
Ibrutinib treatment of a patient with relapsing chronic lymphocytic leukemia and sustained remission of Richter syndrome 107
Dactinomycin induces complete remission associated with nucleolar stress response in relapsed/refractory NPM1-mutated AML 107
A novel NOTCH1 PEST domain mutation in a case of Chronic Lymphocytic Leukemia 105
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 105
Interleukin-7-engineered mesenchymal cells: in vitro effects on naive T-cell population. 105
Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. 104
A microelectronic DNA chip detects the V617F JAK-2 mutation in myeloproliferative disorders 102
. Mismatched hematopoietic stem cell transplants in elderly patients. 102
IN VITRO AND IN VIVO ANTILEUKEMIC ACTIVITY OF BEPRIDIL IN CHRONIC LYMPHOCYTIC LEUKEMIA IS ASSOCIATED WITH INHIBITION OF THE NOTCH1 PATHWAY 99
The human NPM1 mutation A perturbs megakaryopoiesis in a conditional mouse model. 98
Effetto della severità dell'ischemia sul reclutamento delle cellule staminali nei tessuti postischemici: monitoraggio diretto in vivo mediante videomicroscopia 97
ADOPTIVE IMMUNOTHERAPY WITH REGULATORY AND CONVENTIONAL T CELLS AFFORDS HIGH RATE OF CHRONIC GVHD/RELAPSE-FREE SURVIVAL IN ACUTE MYELOID LEUKEMIA AFTER MYELOABLATIVE HAPLOIDENTICAL TRANSPLANTATION 96
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 96
Stem cell mobilization in normal donors. 95
NOTCH1 PEST domain mutation is an adverse prognostic factor in B-CLL. 95
Novel NPM1 exon 5 mutations and gene fusions leading to aberrant cytoplasmic nucleophosmin in AML 95
Nephrotic syndrome in primary myelofibrosis with renal extramedullary hematopoiesis and glomerulopathy in the JAK inhibitor era 94
Acute GvHD after HLA- Haploidentical Hematopoietic Cell Transplantation with Regulatory and Conventional T Cell Immunotherapy Does Not Adversely Affect Transplantation Outcomes 92
Full-haplotype mismatched HSCT for high risk acute myeloid leukemia (AML). 92
BEPRIDIL IS A POTENT NOTCH1 INHIBITOR AND EFFICIENTLY INDUCES APOPTOSIS IN CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL) CELLS in vitro AND in vivo 91
Mismatched hematopoietic stem cell transplantation in secondary leukemia 91
Novel targets for endoplasmic reticulum stress-induced apoptosis in B-CLL. 91
MYB deregulation from a EWSR1-MYB fusion at leukemic evolution of a JAK2 V617F positive primary myelofibrosis 90
REGULATORY T CELL ADOPTIVE IMMUNOTHERAPY PROMOTES B CELL IMMUNITY AFTER HAPLOIDENTICAL TRANSPLANTATION 89
Effetto della severità dell’ischemia sul reclutamento delle cellule staminali nei tessuti postischemici: monitoraggio diretto in vivo mediante videomicrosopia. 89
Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces non-relapse mortality 88
Gefitinib enhances the effects of combined radiotherapy and 5-fluorouracil in a colorectal cancer cell line. 88
NOTCH and NF-κB interplay in chronic lymphocytic leukemia is independent of genetic lesion. 88
A pro-inflammatory environment in bone marrow of Treg transplanted patients matches with graft-versus-leukemia effect 86
The Total Body Irradiation Schedule Affects Acute Leukemia Relapse After Matched T Cell–Depleted Hematopoietic Stem Cell Transplantation 86
New mechanism of lymphoma-induced bone marrow aplasia 86
Hematopoietic stem cell transplantation (HSCT) from alternative donors for acute leukemia at high-risk of relapse. the haploidentical option. 85
Identification and Characterization of Novel Rare Nucleophosmin (NPM1) Gene Mutations in Acute Myeloid Leukemia (AML) By a Combinatorial Approach of Immunohistochemistry and Molecular Analyses 84
The “ultimate” haploidentical transplantation for the elderly with high-risk acute myeloid leukemia 84
Reclutamento delle cellule staminali nei tessuti postischemici: valutazione diretta in vivo mediante videomicroscopia 83
Mesenchymal cells recruit and regulate T regulatory cells. 83
Prognostic significance of genetic variants in the IL-23/Th17 pathway for the outcome of T cell-depleted allogeneic stem cell transplantation. 81
Full haplotype mismatched transplant in high risk acute leukemia patients. 80
Full-haplotype mismatched HSCT is a valid option for high-risk acute myeloid leukemia (AML) patients. 78
Hematopoietic stem cell transplantation from alternative donors for high-risk acute leukemia: the haploidentical option. 77
Stem cell transplantation from full-haplotype mismatched donors in leukemia . 76
Homing and survival of thymidine kinase-transduced human T cells in NOD/SCID mice 76
Distribution of active alpha and beta subunit of beta-N-acetylhexosaminidase as a function of leukaemic cell types 76
MOLECULAR AND BIOLOGICAL BASIS OF THE ASOCIATION OF RADIOTHERAPY, 5-FLUOROURACIL AND GEFITINIB IN RECTAL CANCER 74
NOTCH1 Aberrant Activation Is a Common Nonmutational Early Event in Chronic Lymphocytic Leukemia Hematopoietic Stem-Cells 72
HAPLOIDENTICAL TRANSPLANTATION WITH TREG-TCON ADOPTIVE IMMUNOTHERAPY FOR THE CURE OF ACUTE MYELOID LEUKEMIA WITH HIGH-RISK CYTOGENETICS 71
Outcomes after CD34+ positive immunoselection for haploidentical transplants in high-risk acute leukemia. 71
Trapianto di cellule staminali nei tessuti post-ischemici: studio in vivo degli effetti delle cellule staminali sulla funzione microvascolare. 70
Immunoselection and clinical use of T regulatory cells in HLA-haploidentical stem cell transplantation. 67
Regulatory T Cell Adoptive Immunotherapy Promotes B Cell Immunity after Haploidentical Transplantation 66
Next generation HLA-haploidentical HSCT 65
THE BRAF INHIBITOR VEMURAFENIB IS SAFE AND HIGHLY EFFECTIVE IN REFRACTORY AND RELAPSED HAIRY CELL LEUKEMIA: RESULTS OF THE HCL-PG01 PHASE-2 ITALIAN CLINICAL TRIAL 65
NOTCH and Graft-Versus-Host Disease 65
Hematopoietic stem cell transplantation from alternative donors for high-risk acute leukemia: the haploidentical option. 59
Radioimmunotherapy with 90Y-ibritumomab tiuxetan to treat follicular non Hodgkin-lymphoma in relapse after autologous transplant or refractory to chemotherapy: preliminary results. 58
Homing and survival of thimidine kinase transduced human T-cells in NOD/SCID mice. 55
Uno strano caso di “eritema pernio” delle mani 54
null 37
Totale 9.468
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.189
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.189
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021185 0 0 0 0 0 0 0 0 0 26 59 100
2021/2022974 18 252 18 43 22 10 14 223 12 77 138 147
2022/20231.471 89 275 15 129 119 150 0 61 558 6 49 20
2023/2024746 30 69 37 29 3 20 178 9 46 38 128 159
2024/20251.523 60 141 60 76 198 52 91 98 260 85 255 147
2025/20263.025 220 201 166 411 464 322 511 143 316 271 0 0
Totale 9.468